Underreporting of Melanoma in Arizona and Strategies for Increasing Reporting: A Public Health Partnership Approach.
Underreporting of Melanoma in Arizona and Strategies for Increasing Reporting: A Public Health Partnership Approach.
复制标题
亚利桑那州黑色素瘤的漏报和增加报告的策略：公共卫生伙伴关系方法。
DOI：
10.1177/003335491513000624
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
Flood,TimothyJ
中科院分区：
文献类型：
--
作者：
Harris,RobinB;Koch,StephanieM;Newton,Chris;Silvis,NancyG;Curiel-Lewandroski,Clara;Giancola,Joseph;Sagerman,Paul;Alder,Steven;Yee,Georgia;Flood,TimothyJ
据报道，黑色素瘤的发病率在美国呈上升趋势。1-3美国癌症协会报告说，从1999年到2008年，男性和女性的癌症发病率每年增加2.1%到2.4%。在亚利桑那州，1999年至2001年的年龄调整黑色素瘤发病率也有所增加，但略高于美国整体水平。然而，在2005-2007年的一份报告中，亚利桑那州男性黑色素瘤的发病率比美国低30%，亚利桑那州女性黑色素瘤的发病率比美国低21%。5这种趋势变化的原因尚不清楚。在亚利桑那州，癌症数据管理由亚利桑那州癌症登记处（ACR）负责。[6] 1992年，《亚利桑那州修订法规》第36-133条规定，医院、诊所和医生必须报告所有癌症病例，包括黑色素瘤。ACR是一个被动的登记处，这意味着ACR人员不会主动访问病理实验室或医疗服务提供者办公室来识别和提取癌症病例。相反，登记处仅依赖于向ACR发送适当表格的供应商，尽管ACR确实与大量供应商和实验室进行质量控制。尽管ACR被认为是一个覆盖率超过95%的基于人群的注册中心，但它在2003年失去了大量资金，这导致了更少的质量控制访问，以确保合规性。癌症发病率是根据州癌症登记处保存的数据计算的，这些数据高度依赖于社区来源（包括医生）的癌症病例实际报告。黑色素瘤漏报的可能性特别高，因为它经常在门诊进行诊断和治疗。8，9 2012年，由于担心亚利桑那州观察到的黑色素瘤发病率下降代表了漏报，而不是真实的变化，因此成立了一个临时的全州公共卫生合作伙伴关系，以评估黑色素瘤漏报的程度，确定报告的障碍提供者，并建议增加报告的策略。我们描述的伙伴关系，亚利桑那州的问题的严重性，确定增加报告的战略，以及实施新战略后的结果。
The incidence of melanoma has been reported as increasing in the United States. 1–3 The American Cancer Society reported a 2.1% to 2.4% annual increase in rates from 1999 to 2008 for men and women. 3 In Arizona, the age-adjusted melanoma incidence rates from 1999 to 2001 were reported as also increasing but slightly higher than for the United States as a whole. 4 However, in a 2005–2007 report, the incidence rates for melanoma were 30% lower for Arizona men and 21% lower for Arizona women than the US rates. 5 Reasons for this change in trends were not known. In Arizona, cancer data management is the responsibility of the Arizona Cancer Registry (ACR). 6 In 1992, reporting of all cancer cases, including melanoma, by hospitals, clinics, and physicians became mandatory by Arizona Revised Statutes § 36-133. 7 The ACR is a passive registry, meaning that ACR personnel do not actively visit pathology laboratories or health provider offices to identify and abstract cancer cases. Instead, the registry relies solely on providers sending appropriate forms to the ACR, although the ACR does perform quality control with high-volume providers and laboratories. Although the ACR is considered a population-based registry with more than 95% coverage, it lost substantial funding in 2003, which resulted in fewer quality-control visits to assure compliance. Cancer incidence rates are calculated from data maintained by state cancer registries, and these data are highly dependent on the actual reporting of cancer cases from community sources, including physicians. The potential for underreporting can be especially high with melanoma, as it is frequently diagnosed and treated in outpatient settings. 8, 9In 2012, because of concerns that the observed drop in melanoma incidence in Arizona represented underreporting rather than real change, an ad hoc statewide public health partnership was formed to assess the degree of underreporting of melanoma, identify barriers to reporting by providers, and recommend strategies for increasing reporting. We describe the partnership, the magnitude of the problem for Arizona, strategies identified to increase reporting, and results after implementing new strategies.
DOI：
10.1038/jid.2008.423
发表时间：
2009-07
期刊：
The Journal of investigative dermatology
影响因子：
--
作者：
通讯作者：
--
影响因子：
13.8
作者：
Cartee, Todd V.;Kini, Seema P.;Chen, Suephy C.
通讯作者：
Chen, Suephy C.
马萨诸塞州皮肤恶性黑色素瘤的系统性漏报。
影响因子：
13.8
作者：
Koh,HK;Clapp,RW;Barnett,JM;Nannery,WM;Tahan,SR;Geller,AC;Bhawan,J;Harrist,TJ;Kwan,T;Stadecker,M
通讯作者：
Stadecker,M